Durability of responses with biweekly dosing of teclistamab in patients with relapsed/refractory multiple myeloma achieving a clinical response in the MajesTEC-1 study Meeting Abstract
| Authors: | Usmani, S. Z.; Karlin, L.; Benboubker, L.; Nahi, H.; San-Miguel, J.; Trancucci, D.; Qi, K.; Stephenson, T.; Puchalt, A. P.; Chastain, K.; Chari, A. |
| Abstract Title: | Durability of responses with biweekly dosing of teclistamab in patients with relapsed/refractory multiple myeloma achieving a clinical response in the MajesTEC-1 study |
| Meeting Title: | Clinical Lymphoma Myeloma & Leukemia |
| Keywords: | multiple myeloma; phase ii; mm; relapsed/refractory multiple myeloma; bispecifics |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Sep 6-9 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S477 |
| Language: | English |
| ACCESSION: | WOS:001062479600543 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01410-6 |
| Notes: | Meeting Abstract: MM-162 -- Source: Wos |
